Translational Development Acquisition Corp. · NASDAQ:TDAC
Meteora Capital, LLC's stake in Translational Development Acquisition Corp. fell to 3.08% (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Meteora Capital, LLC's stake in Translational Development Acquisition Corp. fell to 3.08%, 595,464 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 3.08%
- Shares
- 595,464
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Meteora Capital, LLC | 3.08% | 595,464 |
Source
Download original · View original at SEC
Related
- Translational Development Acquisition Corp.
- Meteora Capital, LLC
- Translational Development Acquisition Corp. shareholders
- Schedule 13G · Meteora Capital, LLC · Aug 14, 2026
- Schedule 13G/A · AQR Capital Management LLC · Nov 16, 2026
- Schedule 13G/A · Magnetar Financial LLC · Nov 13, 2026
- Schedule 13G/A · Linden Advisors LP · Aug 14, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2026
- Schedule 13G/A · Wolverine Asset Management LLC · Jul 16, 2026